71 related articles for article (PubMed ID: 34433910)
21. Modulation of antioxidant enzymes, SIRT1 and NF-κB by resveratrol and nicotinamide in alcohol-aflatoxin B1-induced hepatocellular carcinoma.
Rawat D; Chhonker SK; Naik RA; Koiri RK
J Biochem Mol Toxicol; 2021 Jan; 35(1):e22625. PubMed ID: 32894639
[TBL] [Abstract][Full Text] [Related]
22. The Role of SIRT1 on DNA Damage Response and Epigenetic Alterations in Cancer.
Alves-Fernandes DK; Jasiulionis MG
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261609
[TBL] [Abstract][Full Text] [Related]
23. From NASH to HCC: current concepts and future challenges.
Anstee QM; Reeves HL; Kotsiliti E; Govaere O; Heikenwalder M
Nat Rev Gastroenterol Hepatol; 2019 Jul; 16(7):411-428. PubMed ID: 31028350
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular Carcinoma.
Villanueva A
N Engl J Med; 2019 Apr; 380(15):1450-1462. PubMed ID: 30970190
[No Abstract] [Full Text] [Related]
25. N-acetylcysteine decreases malignant characteristics of glioblastoma cells by inhibiting Notch2 signaling.
Deng J; Liu AD; Hou GQ; Zhang X; Ren K; Chen XZ; Li SSC; Wu YS; Cao X
J Exp Clin Cancer Res; 2019 Jan; 38(1):2. PubMed ID: 30606241
[TBL] [Abstract][Full Text] [Related]
26. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
[TBL] [Abstract][Full Text] [Related]
27. NRF2 Intensifies Host Defense Systems to Prevent Lung Carcinogenesis, but After Tumor Initiation Accelerates Malignant Cell Growth.
Satoh H; Moriguchi T; Saigusa D; Baird L; Yu L; Rokutan H; Igarashi K; Ebina M; Shibata T; Yamamoto M
Cancer Res; 2016 May; 76(10):3088-96. PubMed ID: 27020858
[TBL] [Abstract][Full Text] [Related]
28. Nrf2 facilitates repair of radiation induced DNA damage through homologous recombination repair pathway in a ROS independent manner in cancer cells.
Jayakumar S; Pal D; Sandur SK
Mutat Res; 2015 Sep; 779():33-45. PubMed ID: 26133502
[TBL] [Abstract][Full Text] [Related]
29. Global cancer statistics, 2012.
Torre LA; Bray F; Siegel RL; Ferlay J; Lortet-Tieulent J; Jemal A
CA Cancer J Clin; 2015 Mar; 65(2):87-108. PubMed ID: 25651787
[TBL] [Abstract][Full Text] [Related]
30. Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: significance of combination therapy.
Amini A; Masoumi-Moghaddam S; Ehteda A; Morris DL
J Exp Clin Cancer Res; 2014 Nov; 33(1):92. PubMed ID: 25425315
[TBL] [Abstract][Full Text] [Related]
31. NAD+ and sirtuins in aging and disease.
Imai S; Guarente L
Trends Cell Biol; 2014 Aug; 24(8):464-71. PubMed ID: 24786309
[TBL] [Abstract][Full Text] [Related]
32. 'Liver let die': oxidative DNA damage and hepatotropic viruses.
Higgs MR; Chouteau P; Lerat H
J Gen Virol; 2014 May; 95(Pt 5):991-1004. PubMed ID: 24496828
[TBL] [Abstract][Full Text] [Related]
33. Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis.
Satoh H; Moriguchi T; Takai J; Ebina M; Yamamoto M
Cancer Res; 2013 Jul; 73(13):4158-68. PubMed ID: 23610445
[TBL] [Abstract][Full Text] [Related]
34. SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma.
Mao B; Hu F; Cheng J; Wang P; Xu M; Yuan F; Meng S; Wang Y; Yuan Z; Bi W
Oncogene; 2014 Mar; 33(11):1468-74. PubMed ID: 23542177
[TBL] [Abstract][Full Text] [Related]
35. Antitumor effect of SIRT1 inhibition in human HCC tumor models in vitro and in vivo.
Portmann S; Fahrner R; Lechleiter A; Keogh A; Overney S; Laemmle A; Mikami K; Montani M; Tschan MP; Candinas D; Stroka D
Mol Cancer Ther; 2013 Apr; 12(4):499-508. PubMed ID: 23339189
[TBL] [Abstract][Full Text] [Related]
36. Targeting of Nrf2 induces DNA damage signaling and protects colonic epithelial cells from ionizing radiation.
Kim SB; Pandita RK; Eskiocak U; Ly P; Kaisani A; Kumar R; Cornelius C; Wright WE; Pandita TK; Shay JW
Proc Natl Acad Sci U S A; 2012 Oct; 109(43):E2949-55. PubMed ID: 23045680
[TBL] [Abstract][Full Text] [Related]
37. Glutathione and modulation of cell apoptosis.
Circu ML; Aw TY
Biochim Biophys Acta; 2012 Oct; 1823(10):1767-77. PubMed ID: 22732297
[TBL] [Abstract][Full Text] [Related]
38. Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance.
Wang RH; Kim HS; Xiao C; Xu X; Gavrilova O; Deng CX
J Clin Invest; 2011 Nov; 121(11):4477-90. PubMed ID: 21965330
[TBL] [Abstract][Full Text] [Related]
39. Acetylation-deacetylation of the transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2) regulates its transcriptional activity and nucleocytoplasmic localization.
Kawai Y; Garduño L; Theodore M; Yang J; Arinze IJ
J Biol Chem; 2011 Mar; 286(9):7629-40. PubMed ID: 21196497
[TBL] [Abstract][Full Text] [Related]
40. SIRT1 contributes to telomere maintenance and augments global homologous recombination.
Palacios JA; Herranz D; De Bonis ML; Velasco S; Serrano M; Blasco MA
J Cell Biol; 2010 Dec; 191(7):1299-313. PubMed ID: 21187328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
